Development of Vaccine Strategies for the Treatment of B-Cell Malignancies
- 1 January 1997
- journal article
- research article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 15 (6) , 577-587
- https://doi.org/10.3109/07357909709047600
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Approaches to Augmenting the Immunogenicity of Melanoma Gangliosides: From Whole Melanoma Cells to Ganglioside‐KLH Conjugate VaccinesImmunological Reviews, 1995
- Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes.The Journal of Experimental Medicine, 1994
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993
- Induction of syngeneic cytotoxic T lymphocytes against a B cell tumorCellular Immunology, 1992
- Humoral and cell-mediated immune responses to live recombinant BCG–HIV vaccinesNature, 1991
- Antigen Recognition by Class I-Restricted T LymphocytesAnnual Review of Immunology, 1989
- Characterization of a T-cell clone recognizing idiotypes as tumor-associated antigensCellular Immunology, 1988
- Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II moleculesEuropean Journal of Immunology, 1986
- Immunization with the Light Chain and the VL Domain of the Isologous Myeloma Protein 315 Inhibits Growth of Mouse Plasmacytoma MOPC315Scandinavian Journal of Immunology, 1980
- Antibody to a molecularly-defined antigen confined to a tumour cell surfaceNature, 1975